Compass Pathways appoints Lori Englebert as Chief Commercial Officer

New executive appointment made ahead of pivotal study results, potential regulatory approval and subsequent commercialization of investigational COMP360 psilocybin treatment Latest of several key executive team hires, rounding out team to take Compass through phase 3 and beyond Lori brings multifaceted experience in global pharmaceuticals and joins from Axsome Therapeutics, where she spent nearly five years as a member of the executive team serving as head of commercial and business development and most rec ...